These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6395839)

  • 41. Calcium-channel antagonists in cardiovascular disease.
    Holdright DR
    Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?].
    Martsevich SIu
    Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nisoldipin: a vasoselective calcium antagonist].
    Fortschr Med Suppl; 1987; 30():1-22. PubMed ID: 2884178
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of angina pectoris with calcium antagonists].
    Hopf R; Becker HJ; Kober G; Dowinsky S; Kaltenbach M
    Herz; 1982 Aug; 7(4):221-34. PubMed ID: 6751971
    [No Abstract]   [Full Text] [Related]  

  • 45. [Calcium-blockers or calcium antagonists].
    Chávez Rivera I
    Arch Inst Cardiol Mex; 1982; 52(3):259-67. PubMed ID: 7052003
    [No Abstract]   [Full Text] [Related]  

  • 46. Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Kessel D
    Biochem Pharmacol; 1986 Aug; 35(16):2825-6. PubMed ID: 2943288
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.
    Hamann SR; Blouin RA; Chang SL; Kaltenborn KE; Tan TG; McAllister RG
    J Pharmacol Exp Ther; 1984 Nov; 231(2):301-5. PubMed ID: 6491984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative evaluation of the vasodilator effect of verapamil, nifedipine and diltiazem on isolated perfused coronary arteries of rabbit.
    Kaur AH; Singh M; Singh J
    Indian J Physiol Pharmacol; 1984; 28(3):206-10. PubMed ID: 6519762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium channel blockers. New treatment for cardiovascular disease.
    Rossi LP; Antman EM
    Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460
    [No Abstract]   [Full Text] [Related]  

  • 50. Calcium channel antagonists and inhibition of human sphincter of Oddi contractions.
    Sand J; Arvola P; Nordback I
    Scand J Gastroenterol; 2005 Dec; 40(12):1394-7. PubMed ID: 16293553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diastolic properties of the left ventricle in hypertensive cardiopathy. Acute effect of nifedipine, verapamil and diltiazem].
    Alonso Gómez AM; Monreal F; Villafranca JL; Cabello JB; de Diego JM
    Rev Esp Cardiol; 1984; 37(3):169-74. PubMed ID: 6505349
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B; Ayala I; Castells MT; Doménech G; Sánchez-Polo MT; García-Partida P; Valdés M
    Biomed Pharmacother; 2005; 59(1-2):1-7. PubMed ID: 15740928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
    Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
    [No Abstract]   [Full Text] [Related]  

  • 56. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of the tocolytic and hemodynamic effects of calcium channel blockers in pregnant rats].
    Maksimenko EI; Zaĭtsev AA; Aĭlamazian EK; Ignatov IuD; Mikhaĭlov AA
    Eksp Klin Farmakol; 1997; 60(6):25-7. PubMed ID: 9460592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium antagonists (calcium channel blockers).
    Lorimer AR
    Scott Med J; 1981 Apr; 26(2):99-100. PubMed ID: 6270787
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of binding sites for calcium channel antagonists.
    Nakayama H; Kuniyasu A
    Jpn Heart J; 1996 Sep; 37(5):643-50. PubMed ID: 8973377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.